Join to View Full Profile
1300 E Marshall StRichmond, VA 23298
Phone+1 804-628-5054
Fax+1 804-828-7825
Dr. Clark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2004 - 2007
Virginia Commonwealth University School of MedicineClass of 2004
Certifications & Licensure
VA State Medical License 2004 - 2026
TN State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
- CMS Meaningful Use Stage 1 Certification Cerner Millennium Powerchart, Cerner Millennium FirstNet, Cerner Millennium ProFile, Health Sentry, Healthe Exchange, Cerner Healthe Record, IQHealth and P2 Sentinel (Powered by Sensage), Cerner Corporation, 2013
Clinical Trials
- Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis Start of enrollment: 2011 Jul 01
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma Start of enrollment: 2023 May 09
Roles: Contact, Principal Investigator
- Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics Start of enrollment: 2024 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.Jakob Wirbel, Wael Saber, Michael J Martens, Jonathan U Peled, Tessa M Andermann
Biorxiv. 2026-02-19 - 1 citationsSafety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko, Andre De Menezes Silva Corraes, Vanna N Hovanky
Blood Advances. 2025-12-09 - 4 citationsImpact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.Sameem Abedin, Michael J Martens, Javier Bolaños-Meade, Monzr M Al Malki, Qinghua Lian
Blood Advances. 2025-07-22
Journal Articles
- Treatment of Acute Fibrinous Organizing Pneumonia Following Hematopoietic Cell Transplantation with EtanerceptK Miller, W B Clark, J M McCarty, A A Toor, H M Chung, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
